The Sabin Social and Behavioral Interventions for Vaccination Acceptance Small Grants Program is proud to support researchers from both the University of Nairobi and AMUA Sikhendu Medical Center in Kitale collaborating to design a virtual research project and implement a virtual, community co-developed intervention to mitigate the spread and impact of COVID-19 misinformation in Trans-Nzoia.

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and public health in the midst of the COVID-19 pandemic.

Sabin Vaccine Institute Statement on the Passing of Sabin Founder and Trustee Philip Russell

Major General (Ret) Philip King Russell, physician, scientist, soldier, family man, and global health advocate who dedicated his life to protecting humans from infectious disease through vaccines, died peacefully on January 21, 2021, just a few months after being diagnosed with cancer and one week before his 89th birthday. Phil’s proudest achievement and greatest joy was his large and ever-expanding family, and after living in the Washington, DC area for more than 40 years, Phil and his wife of 65 years, Constance Rice Russell, moved to the Denver area in 2014 to be closer to their family. Phil passed his final days with Connie and his three children (Katherine Russell Kingsbery, Ellen King Russell Herting and Richard Webster Russell) by his side. He is also survived by six grandchildren, Russell Everette Kingsbery, Kelsey Louise Kingsbery, William Webster Kingsbery, Avery Grace Russell, Peyton Christine Russell, Taylor King Russell and three great grandchildren.

By Jamie Minchin, Senior Associate, Vaccine Acceptance and Demand and Meaghan Charlton, Senior Manager, Vaccine Acceptance

Sabin Vaccine Institute Funds Researchers to Investigate COVID-19 Misinformation, Design Solutions to Increase Vaccine Acceptance

The Sabin Vaccine Institute (Sabin) announced today that it has awarded grants to research teams in four countries to explore the social drivers of COVID-19 misinformation, and its impact on routine immunization acceptance and the acceptance of a COVID-19 vaccine.

Dr. Regina Rabinovich Succeeds Dr. Axel Hoos as Sabin Vaccine Institute Board Chair, Drs. Norman Baylor and JoAnn Suzich Join the Board

The Sabin Vaccine Institute (Sabin) is pleased to announce the Board of Trustees has unanimously elected Regina Rabinovich, MD, MPH, as board chair and elected two new trustees, Dr. Norman Baylor and Dr. JoAnn Suzich, to strengthen the organization’s leadership in global immunization and vaccine research and development.

This blog post is part of Sabin’s Vaccine IQ: Intro to Vaccine Research & Development series, in which experts from Sabin’s Vaccine R&D team give an introduction to how vaccines are made, explaining the stages of research, development and testing vaccine candidates must go th

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and public health in the midst of the COVID-19 pandemic.

Pages